Live Breaking News & Updates on Moleculin Biotech Inc|Page 16
Stay updated with breaking news from Moleculin biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moleculin Biotech Inc MBRX provided a preliminary update on recent clinical activity from annamycin lead development programs. Annamycin is the company's… ....
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the stock. Moleculin Biotech Trading Down 5.5 % NASDAQ MBRX opened at $0.56 on Friday. The firm has a market capitalization of $16.54 million, a price-to-earnings […] ....
Moleculin to Report Third Quarter Financial Results on November 13, 2023 and Host Conference Call and Webcast streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Moleculin Biotech (MBRX) presents positive Phase 1B/2 clinical trial evaluating Annamycin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Friday. The firm issued a sell rating on the stock. Moleculin Biotech Price Performance Shares of Moleculin Biotech stock opened at $0.59 on Friday. The business has a 50-day moving average of $0.49 and a 200-day moving average […] ....